Transformation of pharmaceutical care during the Martial state in Ukraine: doctors’ perception of interprofessional communication
More details
Hide details
1
SHUPYK NATIONAL HEALTHCARE UNIVERSITY OF UKRAINE, KYIV, UKRAINE
2
ZHAPORIZHZHIA STATE MEDICAL AND PHARMACEUTICAL UNIVERSITY, ZHAPORIZHZHIA, UKRAINE
Publication date: 2005-05-30
Wiadomości Lekarskie 2025;(5):1143-1153
KEYWORDS
ABSTRACT
Aim: To investigate the perception of general practitioners of family medicine of the implementation of Good Pharmacy Practice (GPP) standards by pharmacists
to determine approaches to interprofessional communication and further integration of pharmacists into primary health care.
Materials and Methods: The study was conducted at the Department of Cardiology of the Shupyk National Healthcare University of Ukraine from March to
December 2024 by means of an anonymous online survey using Google Forms. The methods of analysis, deduction, induction, comparison, systematization,
generalization, forecasting, statistics and bibliography were used.
Results: The functions of pharmacists in integrated care teams were determined: monitoring and compatibility of medicines, monitoring the effectiveness of
pharmacotherapy, dispensing prescription medicines “only on prescription” (72.5% [CI 95% 72.5 ± 0.02, p<0.0001]); joint training in the process of continuous
professional development (4.8% [CI 95% 4.8 ± 0.01, p<0.0001]). It was found that the level of clinical competencies of pharmacists (65.3% [CI 95% 65.3 ±
0.03, p<0.0001]) and safe use of medicines (60.7% [CI 95% 60.7, ± 0.03, p<0.0001]) is mediocre.
Conclusions: The high interest of doctors of therapeutic specialties in interprofessional communication with pharmacists as part of integrated care teams was
determined (72.5% [CI 95% 72.5 ± 0.02, p<0.0001]). The need for additional training of pharmacists in the process of continuous professional development for
work as part of integrated care teams in order to obtain and deepen clinical competencies was substantiated. We see the development of clinical recommen
dations
for community pharmacists in accordance with the ESC/AHA recommendations and taking into account the compatibility of medicines when providing
pharmaceutical care to patients with ischemic heart disease with comorbid conditions as a prospect for further research